Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells

Brain Research
G WiemerH Gögelein

Abstract

We studied whether primary cultured porcine brain capillary endothelial cells (PBCEC) respond to bradykinin with an enhanced intracellular cytosolic calcium concentration [Ca2+]i with subsequent formation of nitric oxide (NO) and prostacyclin (PGI2). In addition we examined whether these cells synthetize and release kinins that may accumulate during angiotensin-converting enzyme (ACE) inhibition. [Ca2+]i was assessed by the fluorescent dye Fura-2, NO formation by determination of intracellular cyclic GMP and PGI2 by a specific radioimmunoassay for 6-ketoprostaglandin F1 alpha. Bradykinin and the ACE inhibitor ramiprilat concentration-dependently increased the formation of cyclic GMP which was completely prevented by the stereospecific inhibitor of NO synthase, NG-nitro-L-arginine. Also the specific B2-kinin receptor antagonist icatibant (Hoe 140) abolished the increase in cyclic GMP as well as the ramiprilat-induced increase in PGI2 formation. The data demonstrate the existence of B2-kinin receptors and ACE activity in PBCEC. Moreover PBCEC are capable of producing and releasing kinins in amounts that lead via stimulation of B2-kinin receptors to an enhanced [Ca2+]i as well as NO and PGI2 synthesis and release, provided that de...Continue Reading

References

Apr 1, 1978·The Anatomical Record·Y J Le Beux, J Willemot
Jan 1, 1992·Journal of Cardiovascular Pharmacology·M HeckerR Busse
Jan 1, 1992·Journal of Cardiovascular Pharmacology·C FrelinP Vigne
Mar 16, 1992·Biochemical and Biophysical Research Communications·P Vigne, C Frelin
Mar 1, 1991·British Journal of Pharmacology·F J HockJ Knolle
Jul 1, 1991·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P Homayoun, S I Harik
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P KubesD N Granger
Apr 15, 1991·Neuroscience Letters·Y IshizakiS Murota
Jan 1, 1992·Journal of Neurochemistry·F Joó
Mar 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S I HarikA P Dick
Oct 1, 1988·Pflügers Archiv : European journal of physiology·A LückhoffR Busse
Oct 1, 1987·The American Journal of Physiology·R Morgan-BoydA Hassid
Sep 1, 1986·Scientific American·G W Goldstein, A L Betz

❮ Previous
Next ❯

Citations

Jul 1, 1996·European Journal of Nuclear Medicine·M RodriguesH Sinzinger
Dec 24, 1995·Brain Research·E SanovichM W Brightman
Jun 1, 1997·Immunopharmacology·D M RaidooK D Bhoola
Dec 22, 1999·Immunopharmacology·M CerfK Bhoola
Sep 28, 1998·Pharmacology & Therapeutics·D M Raidoo, K D Bhoola
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·M IsshikiA Kamiya
Dec 9, 2004·Atherosclerosis·Valdeci da CunhaYi-Xin Jim Wang
Oct 26, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Guo ZhangPin-Lan Li
May 18, 1999·Pharmacology & Toxicology·J S Petersen
Jun 19, 2007·The Journal of Urology·D Mastrangelo, C E Iselin
Apr 28, 2012·Acta Paediatrica·Robert CottonJeff Reese
Mar 3, 2007·Pharmacological Reviews·Noboru TodaTomio Okamura
Mar 6, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Tal HasinSudhir S Kushwaha
Sep 26, 2017·Neurosurgery·Gerald J RiccardelloChirag D Gandhi
Nov 18, 2000·British Journal of Pharmacology·F PourageaudJ L Freslon
Jun 5, 2003·American Journal of Physiology. Renal Physiology·Andrew Y ZhangAi-Ping Zou
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Sakuji ShigematsuRonald J Korthuis
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Fu-Xian YiPin-Lan Li
Mar 26, 2005·Canadian Journal of Physiology and Pharmacology·Marie-Josée DumoulinDaniel Lamontagne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.